Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria-Reference-Cited by-同舟云学术

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Published:2017-05-03 Issue:6 Volume:32 Page:853-864
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Höglinger Günter U.¹²^ORCID,Respondek Gesine¹²,Stamelou Maria³^ORCID,Kurz Carolin⁴,Josephs Keith A.⁵,Lang Anthony E.⁶,Mollenhauer Brit⁷,Müller Ulrich⁸,Nilsson Christer⁹,Whitwell Jennifer L.¹⁰,Arzberger Thomas²⁴¹¹,Englund Elisabet¹²,Gelpi Ellen¹³,Giese Armin¹¹,Irwin David J.¹⁴,Meissner Wassilios G.¹⁵¹⁶¹⁷^ORCID,Pantelyat Alexander¹⁸,Rajput Alex¹⁹,van Swieten John C.²⁰,Troakes Claire²¹,Antonini Angelo²²,Bhatia Kailash P.²³^ORCID,Bordelon Yvette²⁴,Compta Yaroslau²⁵,Corvol Jean-Christophe²⁶,Colosimo Carlo²⁷,Dickson Dennis W.²⁸,Dodel Richard²⁹,Ferguson Leslie¹⁹,Grossman Murray¹⁴,Kassubek Jan³⁰,Krismer Florian³¹,Levin Johannes²³²,Lorenzl Stefan³³³⁴³⁵,Morris Huw R.³⁶,Nestor Peter³⁷,Oertel Wolfgang H.³⁸,Poewe Werner³¹,Rabinovici Gil³⁹,Rowe James B.⁴⁰,Schellenberg Gerard D.⁴¹,Seppi Klaus³¹,van Eimeren Thilo⁴²,Wenning Gregor K.³¹,Boxer Adam L.³⁹,Golbe Lawrence I.⁴³,Litvan Irene⁴⁴,

Affiliation:

1. Department of Neurology; Technische Universität München; Munich Germany

2. German Center for Neurodegenerative Diseases (DZNE); Munich Germany

3. Second Department of Neurology; Attikon University Hospital, University of Athens; Athens Greece

4. Department of Psychiatry; Ludwig-Maximilians-Universität; Munich Germany

5. Department of Neurology; Mayo Clinic; Rochester Minnesota USA

6. Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease; Toronto Western Hospital; Toronto Canada

7. Paracelsus-Elena Klinik, Kassel, Germany, and University Medical Center Göttingen, Institute of Neuropathology; Göttingen Germany

8. Institute of Human Genetics; Giessen Germany

9. Department of Clinical Sciences, Division of Neurology; Lund University; Lund Sweden

10. Department of Radiology; Mayo Clinic; Rochester Minnesoya USA

11. Center for Neuropathology and Prion Research; Ludwig-Maximilians-Universität; Munich Germany

12. Department of Clinical Sciences; Division of Oncology and Pathology, Lund University; Lund Sweden

13. Neurological Tissue Bank of the Biobank - Hospital Clínic de Barcelona; Universitat de Barcelona, IDIBAPS; Barcelona Spain

14. Frontotemporal Degeneration Center; Department of Neurology, University of Pennsylvania; Philadelphia Pennsylvania USA

15. Université de Bordeaux, Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

16. CNRS, Institut des Maladies Neurodégénératives; UMR 5293 Bordeaux France

17. Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux; Bordeaux France

18. Department of Neurology; Johns Hopkins University; Baltimore Maryland USA

19. Division of Neurology; Royal University Hospital, University of Saskatchewan; Saskatoon SK Canada

20. Department of Neurology; Erasmus Medical Centre; Rotterdam The Netherlands

21. London Neurodegenerative Diseases Brain Bank; Institute of Psychiatry, Psychology and Neuroscience, Kings College London; London United Kingdom

22. Parkinson and Movement Disorders Unit; IRCCS Hospital San Camillo, Venice, and Department of Neurosciences, Padova University; Padova Italy

23. Sobell Department of Motor Neuroscience and Movement Disorders; UCL Institute of Neurology; Queen Square London United Kingdom

24. Department of Neurology; University of California; Los Angeles California USA

25. Parkinson's Disease & Movement Disorders Unit; Neurology Service, Hospital Clinic/IDIBAPS/University of Barcelona; Barcelona, Catalonia Spain

26. Sorbonne Universités, UPMC Univ Paris 06; and INSERM UMRS_1127, CIC_1422; and CNRS UMR_7225; and AP-HP; and ICM, Hôpital Pitié-Salpêtrière, Département des maladies du système nerveux; Paris France

27. Department of Neurology; Santa Maria University Hospital of Terni; Terni Italy

28. Mayo Clinic; Jacksonville Florida USA

29. Department of Geriatric Medicine; University Hospital Essen; Essen Germany

30. Department of Neurology; University of Ulm; Ulm Germany

31. Department of Neurology; Medical University Innsbruck; Innsbruck Austria

32. Department of Neurology; Ludwig-Maximilians-Universität; Munich Germany

33. Institute of Nursing Science and Practice; Paracelsus Medical University; Salzburg Austria

34. Department of Neurology; Hospital Agatharied; Agatharied Germany

35. Department of Palliative Medicine; Munich University Hospital; LMU Munich Munich Germany

36. Department of Clinical Neuroscience; UCL Institute of Neurology; London United Kingdom

37. German Center for Neurodegenerative Diseases (DZNE); Magdeburg Germany

38. Department of Neurology; Philipps Universität; Marburg Germany

39. Memory and Aging Center; Department of Neurology, University of California; San Francisco California USA

40. Department of Clinical Neurosciences; Cambridge University; Cambridge United Kingdom

41. Department of Pathology and Laboratory Medicine; Perelman School of Medicine, University of Pennsylvania; Philadelphia Pennsylvania USA

42. Departments of Nuclear Medicine and Neurology; University of Cologne; Cologne Germany

43. Department of Neurology; Rutgers Robert Wood Johnson Medical School; New Brunswick New Jersey USA

44. Department of Neurology; University of California; San Diego California USA

Funder

Bischof Dr. Karl Golser Stiftung

CurePSP

Deutsche Forschungsgemeinschaft (DFG)

German Center for Neurodegenerative Diseases e.V. (DZNE)

German PSP Gesellschaft

Tau Consortium

UK PSP Association

the International Parkinson and Movement Disorder Society

National Institutes of Health

Medical Research Council

Brains for Dementia Research

Alzheimer's Society and Alzheimer's Research UK

PSP Association and CBD-Solutions

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.26987/fullpdf

Reference50 articles.

1. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia;Steele;Arch Neurol,1964

2. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders;Litvan;J Neuropathol Exp Neurol,1996

3. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration;Dickson;J Neurol,1999

4. Neuropathology of tauopathies: principles and practice;Kovacs;Neuropathol Appl Neurobiol,2015

5. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop;Litvan;Neurology,1996

Cited by 1370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automating the analysis of eye movement for different neurodegenerative disorders;Computers in Biology and Medicine;2024-03

2. The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy;Scientific Reports;2024-02-02

3. Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach;Metabolic Brain Disease;2024-02-02

4. The MAPT P.G324L and P.A406G mutations are associated with progressive supranuclear palsy with atypical features;Parkinsonism & Related Disorders;2024-02

5. Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy;NeuroImage;2024-02